Vanguard Fiduciary Trust
IRLA

Vanguard Fiduciary Trust’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
3,614
+2,452
+211% +$56.4K ﹤0.01% 3812
2026
Q1 		$23.5K Buy
+1,162
New +$233K ﹤0.01% 3930

Other funds holding IRLA

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Fiduciary Trust's IRLA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its IRulya Therapeutics Inc. Common Stock (IRLA) stake by 211% in Q2 2026, buying an estimated $56.4K and bringing the position to 3,614 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3812.

Vanguard Fiduciary Trust first reported a position in IRLA in Q1 2026 and has held it in 2 quarters since. 26 funds tracked by Wall St. Rank hold IRLA as of Q2 2026.

  • Vanguard Fiduciary Trust held 3,614 shares of IRulya Therapeutics Inc. Common Stock worth $65.7K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 2,452 IRulya Therapeutics Inc. Common Stock shares in Q2 2026, an estimated $56.4K.
  • IRulya Therapeutics Inc. Common Stock made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3812 holding.
  • Vanguard Fiduciary Trust first reported a position in IRulya Therapeutics Inc. Common Stock in Q1 2026 and has held it in 2 quarters since.
  • 26 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.